These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner. Levine JB; Martin G; Wilson A; Treistman SN Neurosci Lett; 2003 Aug; 346(3):125-8. PubMed ID: 12853100 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors. Mosley CA; Myers SJ; Murray EE; Santangelo R; Tahirovic YA; Kurtkaya N; Mullasseril P; Yuan H; Lyuboslavsky P; Le P; Wilson LJ; Yepes M; Dingledine R; Traynelis SF; Liotta DC Bioorg Med Chem; 2009 Sep; 17(17):6463-80. PubMed ID: 19648014 [TBL] [Abstract][Full Text] [Related]
24. Ligand binding domain interface: A tipping point for pharmacological agents binding with GluN1/2A subunit containing NMDA receptors. Bledsoe D; Vacca B; Laube B; Klein BG; Costa B Eur J Pharmacol; 2019 Feb; 844():216-224. PubMed ID: 30553788 [TBL] [Abstract][Full Text] [Related]
25. Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors. Zhang JB; Chang S; Xu P; Miao M; Wu H; Zhang Y; Zhang T; Wang H; Zhang J; Xie C; Song N; Luo C; Zhang X; Zhu S Cell Rep; 2018 Dec; 25(13):3582-3590.e4. PubMed ID: 30590034 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators. Zimmerman SS; Khatri A; Garnier-Amblard EC; Mullasseril P; Kurtkaya NL; Gyoneva S; Hansen KB; Traynelis SF; Liotta DC J Med Chem; 2014 Mar; 57(6):2334-56. PubMed ID: 24512267 [TBL] [Abstract][Full Text] [Related]
27. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. Donevan SD; McCabe RT Mol Pharmacol; 2000 Sep; 58(3):614-23. PubMed ID: 10953056 [TBL] [Abstract][Full Text] [Related]
28. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. Whittemore ER; Ilyin VI; Woodward RM J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571 [TBL] [Abstract][Full Text] [Related]
29. Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes. He Y; Mu L; Ametamey SM; Schibli R J Labelled Comp Radiopharm; 2019 Jun; 62(8):552-560. PubMed ID: 31037756 [TBL] [Abstract][Full Text] [Related]
30. Age-dependent effects on social interaction of NMDA GluN2A receptor subtype-selective antagonism. Green TL; Burket JA; Deutsch SI Brain Res Bull; 2016 Jul; 125():159-67. PubMed ID: 27378651 [TBL] [Abstract][Full Text] [Related]
32. The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions. Raines DE; Gioia F; Claycomb RJ; Stevens RJ J Pharmacol Exp Ther; 2004 Oct; 311(1):14-21. PubMed ID: 15166258 [TBL] [Abstract][Full Text] [Related]
33. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits. Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411 [TBL] [Abstract][Full Text] [Related]
34. Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+. Wollmuth LP; Kuner T; Sakmann B J Physiol; 1998 Jan; 506 ( Pt 1)(Pt 1):13-32. PubMed ID: 9481670 [TBL] [Abstract][Full Text] [Related]
35. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices. Izumi Y; Zorumski CF J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830 [TBL] [Abstract][Full Text] [Related]
36. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors. Kloda A; Clements JD; Lewis RJ; Adams DJ Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832 [TBL] [Abstract][Full Text] [Related]
37. Discovery of GluN2A subtype-selective Jiang L; Liu N; Zhao F; Huang B; Kang D; Zhan P; Liu X Acta Pharm Sin B; 2024 May; 14(5):1987-2005. PubMed ID: 38799621 [TBL] [Abstract][Full Text] [Related]
38. The inhibitory potency of local anesthetics on NMDA receptor signalling depends on their structural features. Gronwald C; Vegh V; Hollmann MW; Hahnenkamp A; Garaj V; Hahnenkamp K Eur J Pharmacol; 2012 Jan; 674(1):13-9. PubMed ID: 22079424 [TBL] [Abstract][Full Text] [Related]